While it may seem like it at times Apple isn’t the only smartphone which seeks to be a healthcare tool. Per a post on MobileHealthNews;
“Samsung Galaxy smartphones will be serving as the controlling device for Billerica, Massachusetts-based Insulet Corporation’s tubeless insulin pump devices, the two companies announced today.”
This will be Insulet’s first step towards one day eliminating the PDM which now controls the OmniPod and having the OmniPod controlled from a patient’s smartphone. This move will not just be patient friendly but as we noted the other day a huge savings for Insulet . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.